Halliburton Company
HAL · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $22.18B | $22.94B | $23.02B | $20.30B | $15.29B | $14.45B | $22.41B | $24.00B |
| Research & Development | $411.00M | $426.00M | $408.00M | $345.00M | $321.00M | $309.00M | $404.00M | $390.00M |
| Selling, General & Administrative | $239.00M | $239.00M | $226.00M | $240.00M | $204.00M | $182.00M | $227.00M | $254.00M |
| Operating Expenses | $19.92B | $19.12B | $18.93B | $17.59B | $13.49B | $16.88B | $22.86B | $21.53B |
| Operating Income | $2.26B | $3.82B | $4.08B | $2.71B | $1.80B | -$2.44B | -$448.00M | $2.47B |
| Other Income / (Expense) | -$128.00M | -$227.00M | -$84.00M | -$62.00M | -$34.00M | -$111.00M | -$105.00M | -$99.00M |
| Income Before Taxes | $1.77B | $3.23B | $3.36B | $2.11B | $1.25B | -$3.22B | -$1.12B | $1.81B |
| Provision for Income Taxes | $479.00M | $718.00M | $701.00M | $515.00M | -$216.00M | -$278.00M | $7.00M | $157.00M |
| Net Income | $1.28B | $2.50B | $2.64B | $1.57B | $1.46B | -$2.94B | -$1.13B | $1.66B |
| Diluted EPS | — | — | — | — | — | — | -$1.29 | $1.89 |
| Basic Shares Outstanding | 853.00M | 882.00M | 899.00M | 904.00M | 892.00M | 881.00M | 875.00M | 875.00M |
| Diluted Shares Outstanding | 853.00M | 883.00M | 902.00M | 908.00M | 892.00M | 881.00M | 875.00M | 877.00M |
Analyst Estimates
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $2.34 | $2.30 | $2.52 | 10 | ↑2 ↓6 |
| Dec 2027 | $2.92 | $2.69 | $3.05 | 10 | ↑6 ↓4 |
| Dec 2028 | $3.37 | $3.22 | $3.52 | 3 | ↑1 ↓0 |
| Dec 2029 | $3.35 | $3.35 | $3.35 | 1 | ↑1 ↓0 |
